TY  - RPRT
TI  - Optimized transcriptional signature for evaluation of MEK/ERK pathway baseline activity and long-term modulations in ovarian cancer
AU  - Chesnokov, M. S.
AU  - Yadav, A.
AU  - Chefetz, I.
PY  - 2022
DO  - 10.1101/2022.03.21.485160
UR  - https://www.biorxiv.org/content/10.1101/2022.03.21.485160v1
ID  - 10.1101/2022.03.21.485160
ER  -